NCT07665411

Brief Summary

The purpose of this study is verify the effects of a 16 sessions of a web based resistance training, on balance, neuromuscular performance and symptomatology of fibromyalgia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2023

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 13, 2023

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 9, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 9, 2024

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

June 3, 2026

Completed
21 days until next milestone

First Posted

Study publicly available on registry

June 24, 2026

Completed
Last Updated

June 24, 2026

Status Verified

August 1, 2024

Enrollment Period

1.5 years

First QC Date

June 3, 2026

Last Update Submit

June 17, 2026

Conditions

Keywords

Resistance trainingFibromyalgiaweb based

Outcome Measures

Primary Outcomes (2)

  • Neuromuscular performance - Vertical jump

    A force platform is used to measure the vertical jump of the lower limbs. The greater the vertical jump height in centimeters, the better the performance is considered to be.

    Baseline, after 8 weeks of intervention and after 4 weeks of detraining

  • Neuromuscular performance - Medicine ball throw

    The medicine ball throw test is used to assess neuromuscular performance of the upper limbs. The greater the distance in centimeters, the better the muscle performance is considered to be.

    Baseline, after 8 weeks of intervention and after 4 weeks of detraining

Secondary Outcomes (5)

  • Assessment of postural control based on the variable "Mean velocity of Center of Pressure (CoP)"

    Baseline, after 8 weeks of intervention and after 4 weeks of detraining

  • Assessment of postural control based on the variable "95% confidence ellipse area"

    Baseline, after 8 weeks of intervention and after 4 weeks of detraining

  • Fibromyalgia impact questionnaire

    Baseline, after 8 weeks and after 4 weeks of detraining

  • Symptoms

    Baseline, after 8 weeks of intervention and after 4 weeks of detraining

  • The Short Falls Efficacy Scale International (Short FES-I)

    Baseline, after 8weeks of intervention and after 4 weeks of detraining.

Study Arms (1)

Web-based resistance training program

EXPERIMENTAL

Exercise

Other: Web based resistance training

Interventions

The web-based resistance training protocol was completed over the course of sixteen sessions, with each session lasting fifty minutes and occurring twice a week on alternate days.

Web-based resistance training program

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • medical diagnosis of fibromyalgia according to the American College of Rheumatology criteria
  • at least 18 years old

You may not qualify if:

  • severe comorbidity or any other type of condition that negatively influences participation in the training program,;
  • cognitive disorders
  • heart problems
  • surgeries or fractures in the last 6 months
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Beira Interior

Covilha, Castelo Branco District, 6230-001, Portugal

Location

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

June 3, 2026

First Posted

June 24, 2026

Study Start

February 13, 2023

Primary Completion

August 9, 2024

Study Completion

August 9, 2024

Last Updated

June 24, 2026

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

In accordance with the Declaration of Helsinki, participant privacy and the confidentiality of personal information will be protected throughout the study. The informed consent obtained from participants does not include authorization for public sharing of individual-level data.

Locations